-
Mashup Score: 4
There was a J-shaped association of FT4 with cardiovascular disease and mortality. Low concentrations of TSH were associated with a higher risk of all-cause mortality and cardiovascular disease mortality. The 20–40th percentiles of FT4 and the 60–80th percentiles of TSH could represent the optimal healthy ranges of thyroid function based on the risk of cardiovascular disease and mortality, with more than 5% increase of 10-year composite risk identified for FT4 greater than the 85th percentile in women and men older than 70 years.
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Pediheart Podcast #269: Role Of The Stress Echo In The Monitoring Of The Kawasaki Disease Patient - 2 year(s) ago
This week we discuss the role of the stress echo in the evaluation and follow-up of the patient with Kawasaki disease. What are the present recommendations on the role of this form of imaging in this
Source: www.spreaker.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 3Image of the Week - 4 October 2023 - 2 year(s) ago
Your access to the latest cardiovascular news, science, tools and resources.
Source: www.escardio.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
For decades, there has been controversy about whether testosterone therapy has deleterious effects on the risk of major cardiovascular events in older men. As the number of prescriptions for testosterone therapy has escalated, this controversy has heightened.1 Although some epidemiological studies have suggested an association between testosterone therapy and risk of major cardiovascular events, an equal (or greater) number of epidemiological studies have demonstrated no increase or even a decreased risk associated with testosterone therapy.
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 2
In people with type 2 diabetes and cardiovascular disease in Denmark, frailty was associated with a significantly lower probability of SGLT2-inhibitor or GLP-1 receptor-agonist initiation, despite their benefits. Formulating clear and updated guidelines on the use of SGLT2 inhibitors and GLP-1 receptor agonists in people who are frail with type 2 diabetes and cardiovascular disease should be a priority.
Source: www.thelancet.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
The cohort study focused on annual incidence, prevalence, and mortality linked to a number of cardiovascular conditions between 2015 and 2019.
Source: www.ajmc.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 3Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history - 2 year(s) ago
The life history theory assumes that all organisms are under selective pressure to harvest external resources and allocate them to maximise fitness: only organisms making the best use of energy obtain the greatest fitness benefits. The trade-off of energy spans four functions: maintenance, growth, reproduction, and defence against pathogens. The innovative antihyperglycaemic agents glucagon-like peptide 1 (GLP-1) receptor agonists and sodium-glucose cotransporter 2 (SGLT2) inhibitors decrease bodyweight and have the potential to counter low-grade inflammation.
Source: www.thelancet.comCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 3
Guidelines emphasise the health benefits of bouts of physical activity of any duration. However, the associations of intermittent lifestyle physical a…
Source: www.sciencedirect.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1Association between recently raised anticholinergic burden and risk of acute cardiovascular events: nationwide case-case-time-control study - 2 year(s) ago
Objective To evaluate the association between recently raised anticholinergic burden and risk of acute cardiovascular events in older adults. Design Case-case-time-control study (ie, incorporating a case crossover design and a control crossover design consisting of future cases). Setting Taiwan’s National Health Insurance Research Database. Participants 317 446 adults aged ≥65 who were admitted to hospital because of an incident acute cardiovascular event between 2011 and 2018. Acute cardiovascular events included myocardial infarction, strokes, arrhythmias, conduction disorders, and cardiovascular death. Main outcome measures The anticholinergic burden was measured for each participant by adding up the anticholinergic scores for individual drugs using the Anticholinergic Cognitive Burden Scale. Scores were classified into three levels (0 points, 1-2 points, and ≥3 points). For each participant, anticholinergic burden levels during hazard periods (day −1 to −30 before the cardiovascula
Source: www.bmj.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 16ESC TV Today on ESC 365 – 20 minutes that matter in cardiology - 2 year(s) ago
Insights and advice from cardiovascular experts, summaries of recent papers, and more. Watch videos and listen to podcasts on ESC 365, the cardiology knowledge hub.
Source: esc365.escardio.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
The optimal healthy ranges of #thyroid function defined by the risk of #cardiovascular disease and mortality: systematic review and individual participant data meta-analysis https://t.co/ml2Gfq4B3N #CVD